Showing results (1-10 of 264) with videos related to
Sort By:
Pageof 27
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Novel concepts in androgen receptor blockadeAndrew C Hsieh, Charles J RyanThe Lancet. Oncology|October 5, 2007
Androgen-response elements in hormone-refractory prostate cancer: implications for treatment developmentAndrew C Hsieh, Eric J Small, Charles J RyanThe Oncologist|March 19, 2017
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate CancerXiao X Wei, Andrew C Hsieh, Won Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2010
Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancerAndrew C Hsieh, Davide RuggeroHematology/Oncology Clinics of North America|July 25, 2006
Secondary hormonal manipulations in prostate cancerCharles J RyanAsian Journal of Andrology|April 25, 2014
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistanceMerritt P Edlind, Andrew C HsiehTrends in Cancer|April 10, 2019
The Untranslated Regions of mRNAs in CancerSamantha L Schuster, Andrew C HsiehCell Death & Disease|October 6, 2017
Reciprocal amplification of caspase-3 activity by nuclear export of a putative human RNA-modifying protein, PUS10 during TRAIL-induced apoptosisSujata Jana, Andrew C Hsieh, Ramesh GuptaCancer Research|December 15, 2023
Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate CancerRashmi Mishra, Steven Blinka, Andrew C HsiehTrends in Molecular Medicine|June 23, 2023
ELAC2 is a functional prostate cancer risk alleleSteven Blinka, Rashmi Mishra, Andrew C HsiehPageof 27